Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXF39K
|
||||
Drug Name |
(S)-N-(1-(2-(4-methoxyphenylamino)ethylamino)-4-methyl-1-oxopentan-2-yl)-3-methylbenzamide
|
||||
Synonyms |
CHEMBL64765
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H31N3O3
|
||||
Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](CC(C)C)NC(=O)c2cccc(C)c2)cc1
|
||||
InChI |
InChI=1S/C23H31N3O3/c1-16(2)14-21(26-22(27)18-7-5-6-17(3)15-18)23(28)25-13-12-24-19-8-10-20(29-4)11-9-19/h5-11,15-16,21,24H,12-14H2,1-4H3,(H,25,28)(H,26,27)/t21-/m0/s1
|
||||
InChIKey |
BCHIMBJKORTZTR-NRFANRHFSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.